Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of Safety, Efficacy and Pharmacokinetics of CT-707 in Patients With ALK-positive Non-small Cell Lung Cancer

NCT02695550 is registered in ClinicalTrials.gov with Centaurus Biopharma Co., Ltd. as lead sponsor.

NCT NCT02695550
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02695550 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of Safety, Efficacy and Pharmacokinetics of CT-707 in Patients With ALK-positive Non-small Cell Lung Cancer
Lead sponsor
Centaurus Biopharma Co., Ltd.
Phase
Phase 1
Overall status
Unknown status
Start date
March 31, 2016
Completion date
March 31, 2018
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non-small cell lung cancer